CM
ENTA icon

Caption Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Caption Management’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,400
Closed -$741K – 1541
2022
Q1 		$741K Hold
10,400
– – 0.01% 1054
2021
Q4 		$778K Buy
+10,400
New +$816K 0.01% 1135
2019
Q4 		– Sell
-22,500
Closed -$1.35M – 878
2019
Q3 		$1.35M Buy
+22,500
New +$1.67M 0.07% 318

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Caption Management's ENTA Position: Q2 2022 in Review

Caption Management sold out of Enanta Pharmaceuticals (ENTA) in Q2 2022, closing a stake of 9,000 shares — an estimated $640K sold.

Caption Management first reported a position in ENTA in Q2 2019 and held it in 5 quarters. The position peaked at $1.05M in Q3 2020. 154 funds tracked by Wall St. Rank hold ENTA as of Q2 2022.

  • Caption Management reported no remaining Enanta Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Caption Management sold 9,000 Enanta Pharmaceuticals shares in Q2 2022, an estimated $640K.
  • Caption Management first reported a position in Enanta Pharmaceuticals in Q2 2019 and held it in 5 quarters.
  • Caption Management's Enanta Pharmaceuticals position peaked at $1.05M in Q3 2020.
  • 154 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2022.

Based on Caption Management's 13F filing for Q2 2022, filed 15 Aug 2022.